19 July 2022
The startup for drugs and medical services in India PharmEasy is in discussions with investors to fund $200 million, but at a valuation that may be 15% or even 25% less than the $5.1 billion it received last year.
Stay Connected, Stay Informed –
Don’t miss out on exclusive updates, market trends, and real-time investment opportunities. Be the first to know about the latest unlisted stocks, IPO announcements, and curated Fact Sheets, delivered straight to your WhatsApp.